Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function

Journal of Hepatology

Volumn 47, Issue 3, 2007, Pages 338-347

  Lai, Wai Kwan ^a   Curbishley, Stuart M ^a   Goddard, Sarah ^a   Alabraba, Edward ^a   Shaw, Jean ^a   Youster, Janine ^a   McKeating, Jane ^a   Adams, David H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Dendritic cells; HCV; Human

Indexed keywords

CD123 ANTIGEN; CD86 ANTIGEN; CYTOKINE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANALYTIC METHOD; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES; ANTIGENS, CD86; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; GRANULOCYTE PRECURSOR CELLS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-10; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; LIVER; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PLASMA CELLS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 34547486459     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.03.024     Document Type: Article

References (42)

1. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 36 (2002) S35-S46
2. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
3. Pachiadakis I., Pollara G., Chain B.M., and Naoumov N.V. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?. Lancet Infect Dis 5 (2005) 296-304
4. Kanto T., and Hayashi N. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction. J Gastroenterol 39 (2004) 811-812
5. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
6. Cella M., Facchetti F., Lanzavecchia A., and Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1 (2000) 305-310
7. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5 (1999) 919-923
8. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., and Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120 (2001) 512-524
9. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162 (1999) 5584-5591
10. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190 (2004) 1919-1926
11. Auffermann-Gretzinger S., Keeffe E.B., and Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97 (2001) 3171-3176
12. Szabo G., and Dolganiuc A. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210 (2005) 237-247
13. Wertheimer A.M., Bakke A., and Rosen H.R. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40 (2004) 335-345
14. Piccioli D., Tavarini S., Nuti S., Colombatto P., Brunetto M., Bonino F., et al. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 42 (2005) 61-67
15. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., and Rice C.M. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103 (2004) 1026-1029
16. Goddard S., Youster J., Morgan E., and Adams D.H. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 164 (2004) 511-519
17. Nattermann J., Zimmermann H., Iwan A., von Lilienfeld-Toal M., Leifeld L., Nischalke H.D., et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44 (2006) 945-954
18. Encabo A., Solves P., Mateu E., Sepulveda P., Carbonell-Uberos F., and Minana M.D. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3. Stem Cells 22 (2004) 725-740
19. Lutz M.B. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Immunobiology 209 (2004) 79-87
20. Longman R.S., Talal A.H., Jacobson I.M., Rice C.M., and Albert M.L. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 192 (2005) 497-503
21. Ejrnaes M., Filippi C.M., Martinic M.M., Ling E.M., Togher L.M., Crotty S., et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203 (2006) 2461-2472
22. Takayama T., Nishioka Y., Lu L., Lotze M.T., Tahara H., and Thomson A.W. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66 (1998) 1567-1574
23. Cobbold S.P., Graca L., Lin C.Y., Adams E., and Waldmann H. Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance. Transpl Int 16 (2003) 66-75
24. Morris E.S., MacDonald K.P., Rowe V., Johnson D.H., Banovic T., Clouston A.D., et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103 (2004) 3573-3581
25. Lechman E.R., Keravala A., Nash J., Kim S.H., Mi Z., and Robbins P.D. The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen. Gene Ther 10 (2003) 2029-2035
26. Kim S.H., Lechman E.R., Bianco N., Menon R., Keravala A., Nash J., et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174 (2005) 6440-6448
27. Ato M., Stager S., Engwerda C.R., and Kaye P.M. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 3 (2002) 1185-1191
28. Nattermann J., Zimmermann H., Iwan A., von Lilienfeld-Toal M., Leifeld L., Nischalke H.D., et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44 (2006) 945-954
29. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
30. Nelson D.R., Lauwers G.Y., Lau J.Y., and Davis G.L. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118 (2000) 655-660
31. Leveque C., Grafte S., Paysant J., Soutif A., Lenormand B., Vasse M., et al. Regulation of interleukin 3 receptor alpha chain (IL-3R alpha) on human monocytes by interleukin (IL)-4, IL-10, IL-13, and transforming growth factor beta (TGF-beta). Cytokine 10 (1998) 487-494
32. Ebner S., Hofer S., Nguyen V.A., Furhapter C., Herold M., Fritsch P., et al. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 168 (2002) 6199-6207
33. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77 (2003) 4070-4080
34. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194 (2001) 1823-1834
35. Dzionek A., Inagaki Y., Okawa K., Nagafune J., Rock J., Sohma Y., et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 63 (2002) 1133-1148
36. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77 (2003) 4070-4080
37. Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C., Olson W.C., et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci USA (2004)
38. Feinberg H., Mitchell D.A., Drickamer K., and Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294 (2001) 2163-2166
39. Nattermann J., Zimmermann H., Iwan A., von Lilienfeld-Toal M., Leifeld L., Nischalke H.D., et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44 (2006) 945-954
40. Arima S., Akbar S.M., Michitaka K., Horiike N., Nuriya H., Kohara M., et al. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 11 (2003) 169-174
41. Beckebaum S., Cicinnati V.R., Dworacki G., Muller-Berghaus J., Stolz D., Harnaha J., et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 104 (2002) 138-150
42. Moutaftsi M., Mehl A.M., Borysiewicz L.K., and Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99 (2002) 2913-2921